Objectives

 1: In patients with cancer-associated VTE, compare the efficacy and safety of DOAC vs LWMH

 2: In patients with cancer-associated VTE, when is reasonable to use DOAC instead of LMWH

Session date: 
Monday, May 6, 2019 - 12:30pm to 1:30pm
Speaker Name: 
Dr. Edwin Rosas
Location: 
UCMC
IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.